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High-affinity and low-affinity forms of the human interleukin 2 receptor (IL-
2-R) have been identified on the surface of activated lymphocytes (1, 2). The
high-affinity receptors appear to be essential for IL-2-dependent cellular prolif-
eration (1, 2), while the biological function of the low-affinity binding sites
remains undefined. The postbinding fate of IL-2 associated with high- and low-
affinity receptors also differs. IL-2 binding to the high-affinity sites results in
rapid receptor-mediated endocytosis of the growth factor-receptor complex (1,
3-5), while ligand binding to the low-affinity sites does not lead to internalization
(4,5).
The marked difference in ligand endocytosis mediated by the high- and low-
affinity forms of the IL-2-R points to a basic structural variation. Recently,
several laboratories have assembled chemical crosslinking and receptor reconsti-
tution data which suggest that the high-affinity IL-2-R corresponds to a mem-
brane receptor complex (6-9). This complex is composed of at least two poly-
peptide chains (termed a and #), each of which is independently capable of
binding IL-2. The a chain corresponds to the well-characterized Tac antigen
(10), while the # chain is a recently recognized 70-75 kD glycoprotein(s) that is
not precipitated by the anti-Tac antibody (7-9) . Cell lines have been identified
that express either the a or # chain of the receptor in the absence of the other
chain (4, 8, 9). Because only one of the chains is present, these cells do not
express high-affinity IL-2-R, but rather bind IL-2 with a low or intermediate
affinity. For example, HTLV-I-infected MT-1 cells express only the a chain and
bind IL-2 with a low affinity (apparent Kd of 10-30 nM) (4). The gibbon ape
MLA-144 T cell line and the human natural killer-like YT cell line (11), on the
other hand, express predominantly or exclusively the ,B chain and bind IL-2 with
an intermediate affinity (apparent Kd of 0.6-1 .0 nM) (8, 9). We now report
studies with these cell lines which demonstrate that the ,B chain alone is able to
mediate endocytosis of surface-bound IL-2 as rapidly as the a/,B heterodimeric
high-affinity IL-2-R .
Materials and Methods
Cells.
￿
All human and primate cell lines were maintained in RPMI 1640 containing
10% heat-inactivated FCS. For certain experiments, the YT cells (3 X 105 cells/ml) were
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treated with 10 AM forskolin (Sigma Chemical Co., St. Louis, MO) for 20 h at 37°C to
induce increased expression of the Tac protein (YT').
Receptor Binding Assays.
￿
Receptor numbers and dissociation constants (Kd) were meas-
ured as previously described (1, 2) with minor modifications. The binding assays were
performed in 100 A,1 RPMI 1640, 25 mM Hepes, pH 7.2, 5 mg/ml BSA (1640-BSA)
containing serial dilutions of the labelled probes. IL-2 was radioiodinated as described
(12),while anti-Tac antibody was labelled by reductive methylation (10). Cells and labelled
probes were incubated at 37'C for 8-15 min, followed by separation of bound and free
ligand by immediate centrifugation of the cells through a 400 KI layer of 81 % silicone oil
(phenylmethylpolysiloxane ; Dexter Hysol, New York) and 19% paraffin oil (0-121 ; Fisher
Scientific Co., Philadelphia, PA).
Internalization Time Course.
￿
Cells (10' cells/ml for YT, YT', HUT, and MT-l, and 5
X 10' cells/ml for MLA-144) were first incubated for 5 min at 37°C in 1640-BSA
containing 100 AM chloroquine, a lysomotropic agent that prevents degradation of
internalized IL-2 (1, 3). In the case of unstimulated YT cells, unlabelled anti-Tac antibody
was added at a concentration (80 ag/ml) that eliminated all high- and low-affinity Tac-
dependent binding leaving behind only intermediate-affinity (Kd ^-800 pM) ,B chain
binding sites (9). '
￿
I-IL-2 was then added at final concentrations of 75 pM (YT', HUT)
or 1 nM (YT, MT-1, MLA) to select for high-affinity (a plus fl) and low- to intermediate-
affinity (a or 0) binding, respectively. After 20 min at 0°C, most of the cells (YT, YT',
HUT, MLA) were washed twice with ice-cold 1640-BSA to remove unbound IL-2 and
resuspended at 10' cells/ml (5 X 10' cells/ml ; MLA) in prewarmed (37°C) 1640-BSA
containing 100 AM chloroquine. Anti-Tac (80 Ag/ml) was added to the suspension of
unstimulated YT cells. At selected times, 100-Al aliquots of the cell suspension were
removed and diluted with 1 .2 ml ice-cold 1640-BSA. The cells were gelleted and the
radioactivity in the supernatant was measured to determine the level of 5I-IL-2 that had
dissociated from the receptor sites. The cells were then resuspended in 200 Al of 10 mM
citrate, pH 4, containing 0.14 M NaCl and 50 Ag/ml BSA. After 15 s at 23°C, the cells
were centrifuged through a 400 Al layer of silicone/paraffin oil. The radioactivity in the
cell pellet and in the supernatant above the oil layer was measured to determine the level
of pH 4-resistant, internalized IL-2 and the level of pH 4-sensitive, cell surface-bound
IL-2, respectively.
Pilot experiments with MT-1 cells indicated that a substantial fraction of the '25I-IL-2
that specifically bound to low-affinity Tac receptor sites dissociated during the cell washing
and incubation steps. Therefore, the protocol for the MT-1 cells was modified. Unbound
'25I-IL-2 was not removed after the initial incubation of cells and ligand. Instead, the
suspension was quickly warmed to 37°C and, at selected times, two 100 u1 aliquots (106
cells each) were removed. The cells from one aliquot were pelleted through sili-
cone/paraffin oil and the radioactivity in the cell pellet was measured to determine the
level of cell-associated (internalized and surface-bound) IL-2. The second aliquot was
centrifuged and the cells were resuspended in pH 4 buffer and processed as before.
Radioactivity in the cell pellet was used to determine the level of pH 4-resistant,
internalized IL-2.
Results and Discussion
Previous studies indicated that high-affinity receptors containing the Tac
protein internalized bound IL-2 while low-affinity Tac binding sites did not (1,
3-5). The recent discovery of a second IL-2-binding molecule, 0, and the
demonstration of its role in forming high-affinity, Tac-dependent receptor sites
(7-9) raised the question of whether the ,Q chain was primarily responsible for
ligand internalization. To examine this issue, cells and assay conditions were
selected that allowed analysis of the individual IL-2-binding components. Binding
assays confirmed that the YT cells that we had maintained in culture for 10 mo
had almost exclusively intermediate-affinity (Kd ^" 820 pM) 0 chain binding sitesROBB AND GREENE
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TABLE I
Receptor Numbers and A ffinities
.s.I-IL-2 binding
Binding sites numbers anddissociation constants (Kd) were determined by Scatchard analysis ofIL-2 andantibody
bindingdata (1, 2). Thelargenumber oflow-affinitysites on HUTandMT-I cells prevented accurate determination
of their intermediate-affinity binding sites.
(Table I). The average level of Tac antigen on these cells had gradually declined
until barely detectable levels of high-affinity, Tac-dependent IL-2 binding re-
mained . This high-affinity component of binding was easily eliminated by inclu-
sion of anti-Tac antibody in the assays (9). Stimulation of the YT cells with
forskolin (YT'), however, dramatically increased the level of Tac antigen and of
high-affinity IL-2 binding (Table I), presumably by shifting the intermediate-
affinity f component into high-affinity a/f receptor sites (9). The gibbon ape
cell line MLA-144 appeared to exclusively express the intermediate-affinity ,B
component of binding (Table I) (8). In contrast, the HUT 102112 cell line
displayed a mixture of high- and low-affinity IL-2-binding sites and the MT-1
cell line expressed only low-affinity Tac (a) protein. Based on the results of the
binding assays, conditions were selected (see Materials and Methods) that favored
IL-2 binding to either high-affinity receptors (YT''', HUT) or to intermediate-
and low-affinity # (YT and MLA) and Tac (MT-1)-binding sites.
Examination of the fate of bound IL-2 on unstimulated YT and MLA-144
cells demonstrated that ligand associated with intermediate-affinity 0 chain
receptor sites was rapidly internalized with a t.1 , of 10-15 min (Fig. 1). IL-2
bound to high-affinity receptors on forskolin-stimulated YT cells (YT') and on
HUT 102B2 cells was internalized with similar kinetics (Fig. 1). In each case, the
vast majority of the cell-associated IL-2 eventually entered the cells. In contrast
to the rapid internalization by # protein, IL-2 bound to the abundant low-affinity
Tac (a) sites on MT-I cells was not internalized to a measurable extent (Table
II). Thus, consistent with earlier observations (4, 5), Tac protein by itself was
incapable of internalizing bound ligand. The IL-2 that was internalized by ,Q
receptors on unstimulated YT cells was converted into a TCA-soluble form (t~i,
^-70-80 min) in a lysosomal-dependent fashion, sensitive to chloroquine (data
not shown). This process mimicked degradation of IL-2 after binding to high-
affinity receptors on murine and human cells (1, 3, 4). The similar fates of IL-2
bound to intermediate-affinity 0 chain binding sites and to high-affinity a/#
heterodimers, coupled with the inability of Tac protein to mediate internaliza-
tion, suggests that the ,Q chain provides an essential element for ligand internali-
zation by both types of receptor.
The cytoplasmic domains of cell surface receptors are believed to play an
High affinity Intermediate Lowaffinity ['H]Anti-Tac
Cell type
sites/
cell
Kd
(pm)
affinity
sites/
cell
Kd
(pm)
sites/
cell
Kd
(PM)
binding
(sites/cell)
Y'f 5150 -18.0 12,100 810 5200 -11,000 285
YT* 7,650 14.3 4,000 825 :5500 -11,000 7,890
HUT 102112 7,900 7.2 - - 212,000 12,100 285,000
MT-I <50 - - - 143,000 13,400 172,000
MLA-144 <50 - 1,450 900 <200 - <2001204
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FIGURE 1 . Receptor-mediated internaliza-
tion of "'I-IL-2 by human YT cells, YT cells
treated for 20 h with 10 juM forskolin (Y7"),
human HUT 102112 cells, and gibbon ape
MLA-144 cells. At each time, the level of
radioactivity in the cell supernatant ([I) was
measured to determine the content of un-
bound ligand. The cells were then resus-
pended in pH 4 buffer and centrifuged
through a layer of silicone/paraffin oil. The
radioactivity in the cell pellet was measured
to determine the level of pH 4-resistant, in-
ternalized 1251-IL-2 ("), while the radioactiv-
ity in the supernatant above the oil layer was
used todeterminetheamount of cell surface-
bound '251-IL-2 that was dissociated by the
pH 4buffer (O). The sumof the counts ofall
three fractions (A) is also graphed. Anti-Tac
antibodywasincluded in the unstimulated YT
culture to eliminatethesmallamount ofhigh-
affinity, Tac-dependent IL-2 binding associ-
ated with such cells.
TABLE II
Lack ofInternalization of "'I-IL-2 by Low-affinity Tac Protein
on MT-1 Cells
* Unlabelled IL-2 (100 nM) was included at theoutset oftheincubation to determine
thelevel ofnonspecific binding(coldcompetition).
important role in the interactions that allow receptor-mediated endocytosis to
occur (13). The failure of the Tac antigen to internalize IL-2 is not altogether
surprising, as itscytoplasmicdomain containsonly 13 residues (10). Theeffective
endocytosis of IL-2 by the 0 chain suggests that this protein either contains a
larger cytoplasmic domain or that it is associated with another protein that
permits efficient endocytosis of bound ligand.
In addition to IL-2 internalization, the isolated ,B chain also appears capable of
transducing the ligand binding signal in certain lymphoid cells. For example,
t21I-IL-2 chemical crosslinking studies demonstrated that natural killer cells
express small amounts of ,# chain.' Other studies have shown that cytolytic
activity can be augmented in these cells by the addition oflarge quantities of IL-
2 (14). This IL-2-induced response in NK cells was not blocked by anti-Tac
antibody (14), but was inhibited by anti-IL-2 mAb 1HI I-1A5 (R. J. Robb and
M. E. Neville, unpublished observation), which interferes with IL-2 binding to
' Dukovick, M., Y. Wano, Le Thi Bich Thuy, P. Katz, B. R. Cullen, J. H. Kehrl, and W. C.
Greene. Identification of a second human interleukin 2 binding protein and its role in the assembly
of the high-affinity IL-2 receptor. Manuscript submitted forpublication.
Time
min
Total "5I-IL-2 bound
cpm
Internalized `1-IL-2
cpm
0 19,045 312
10 19,337 497
20 19,727 389
30 19,436 595
60 18,555 473
80 19,145 381
cc* 441 299ROBB AND GREENE
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the ,0 chain receptor (9). Similarly, SKW6.4 B cells were shown to express the ,0
chain receptor in the absence of Tac antigen,' and exposure of these cells to
large quantities of IL-2 resulted in increased immunoglobulin secretion (15).
Once again, this response was not blocked by anti-Tac, but was inhibited by the
1H11 antibody (15) . Finally, IL-2 was found to induce the expression of Tac
protein on YT cells in a manner sensitive to inhibition by 1H11 antibody, but
insensitive to anti-Tac (our unpublished observation). Thus, it seems likely that
the isolated ,0 chain of the IL-2-R is capable of signal transduction. It remains
unresolved, however, as to whether receptor endocytosis is required for these
responses. Furthermore, it is unclear whether signalling through the isolated ,0
chain is limited to the transduction of differentiation signals, or whether this IL-
2 binding protein, like the high-affinity IL-2-R, is also capable of transducing
signals resulting in cellular proliferation.
Summary
High-affinity IL-2-R correspond to a membrane receptor complex composed
of two different IL-2-binding proteins, the Tac antigen (a chain) and a 70-75
kD a chain. Using cell lines that express either the a or the a protein, we
demonstrate that IL-2 internalization occurs when ligand is bound to theisolated
# chain, but not when it is bound to the isolated a chain. The kinetics of IL-2
internalization mediated by theintermediate-affinity ,0 chain were nearly identical
to those of the high-affinity a/,0 heterodimer (t~l, of 10-15 min), and each type
of receptor targeted the bound IL-2 for intracellular degradation in lysosomes.
The ,0 chain thus appeared to provide the essential element necessary for ligand
internalization by both types of IL-2-R.
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